Cargando…
Aurora kinase inhibitors: Progress towards the clinic
The Aurora kinases (serine/threonine kinases) were discovered in 1995 during studies of mutant alleles associated with abnormal spindle pole formation in Drosophila melanogaster. They soon became the focus of much attention because of their importance in human biology and association with cancer. Au...
Autores principales: | Kollareddy, Madhu, Zheleva, Daniella, Dzubak, Petr, Brahmkshatriya, Pathik Subhashchandra, Lepsik, Martin, Hajduch, Marian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484309/ https://www.ncbi.nlm.nih.gov/pubmed/22350019 http://dx.doi.org/10.1007/s10637-012-9798-6 |
Ejemplares similares
-
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
por: Kotulová, Jana, et al.
Publicado: (2021) -
QSAR Study on a Series of Protein Tyrosine Phosphatase 1B Inhibitors
por: Mehta, Rajendra S., et al.
Publicado: (2008) -
Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review
por: Gavriilidis, Paschalis, et al.
Publicado: (2015) -
Antiviral Activity of Selected Lamiaceae Essential Oils and Their Monoterpenes Against SARS-Cov-2
por: Ćavar Zeljković, Sanja, et al.
Publicado: (2022) -
Amino-BODIPY as the ratiometric fluorescent sensor for monitoring drug release or “power supply” selector for molecular electronics
por: Porubský, Martin, et al.
Publicado: (2019)